Your Best Stock

Eli Lilly and Co LLY

US equityMarket cap rank #12Drug Manufacturers - General
$1,188.19
+$37.20 (+3.23%)
Market open · Sep 24, 2:00 pm ET
After hours $1,152.12 +0.10%
Open$1,157.90
Prev close$1,150.99
Day range$1,151.01 – $1,197.75
Volume1.36M
Market cap$1.12T
P/E (TTM)39.9
Dividend yield0.54%

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$22.97B+47.7% YoY
Operating profit$12.46B+77.4% YoY
Net profit$7.10B+25.3% YoY
Diluted EPS$7.94+26.2% YoY
Free cash flow$4.48B+248.8% YoY
Operating cash flow$10.69B

Revenue, last 8 quarters

$11.4BSep '24$13.5BDec '24$12.7BMar '25$15.6BJun '25$17.6BSep '25$19.3BDec '25$19.8BMar '26$23.0BJun '26

Net profit, last 8 quarters

$970.3MSep '24$4.4BDec '24$2.8BMar '25$5.7BJun '25$5.6BSep '25$6.6BDec '25$7.4BMar '26$7.1BJun '26

Diluted EPS by quarter

1.07Sep '244.88Dec '243.06Mar '256.29Jun '256.21Sep '257.39Dec '258.26Mar '267.94Jun '26

Free cash flow by quarter

$-458.9MSep '24$726.3MDec '24$-1.6BMar '25$1.3BJun '25$6.0BSep '25$254.2MDec '25$2.8BMar '26$4.5BJun '26

Annual revenue

$24.5BFY20$28.3BFY21$28.5BFY22$34.1BFY23$45.0BFY24$65.2BFY25

Profitability & balance sheet

Gross margin83.4%
Operating margin49.7%
Net margin33.5%
Return on equity102.4%
Return on assets22.0%
Return on invested capital36.4%
Current ratio1.35
Liabilities / assets76.2%
Cash & investments$8.95B
Total debt$54.91B
Net cash (debt)-$45.96B
Free cash flow / sales17.0%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $22.97B $19.80B $65.18B $19.29B $17.60B
Total Operating Revenue $22.97B $19.80B $65.18B $19.29B $17.60B
Cost of Revenue $3.27B $3.58B $11.05B $3.37B $3.01B
Gross Profit $19.71B $16.22B $54.13B $15.92B $14.59B
Operating Expense $7.25B $6.44B $24.43B $6.93B $6.21B
Selling and Admin Expenses $3.43B $2.93B $11.09B $3.13B $2.74B
Research & Development $3.82B $3.51B $13.34B $3.80B $3.47B
Operating Profit $12.46B $9.78B $29.70B $8.99B $8.39B
Other Income (Expense) -$3.21B -$928.00M -$3.97B -$1.24B -$1.04B
Special Income (Charges) -$3.48B -$863.00M -$3.39B -$612.90M -$1.02B
-Less:Other Special Charges $3.48B $584.00M $2.91B $528.80M $655.70M
Other Non-Operating Income (Expenses) $269.00M -$65.00M -$571.00M -$613.30M -$65.40M
Pretax Profit $9.25B $8.85B $25.73B $8.27B $7.23B
Tax $2.15B $1.45B $5.09B $1.63B $1.65B
Net Profit $7.10B $7.40B $20.64B $6.64B $5.58B
Profit from Continuing Operations $7.10B $7.40B $20.64B $6.64B $5.58B
Net Income to Parent Company $7.10B $7.40B $20.64B $6.64B $5.58B
Net Income to Common Stockholders $7.10B $7.40B $20.64B $6.64B $5.58B
Basic EPS $7.95 $8.27 $23.00 $7.42 $6.22
Diluted EPS $7.94 $8.26 $22.95 $7.39 $6.21
Dividend Per Share $1.73 $1.73 $6.00 $1.50 $1.50
-Less:Write Off – $279.00M $484.00M $84.10M $364.90M
-Less:Restructuring and Mergern & Acquisition – – $2.91B $528.80M $655.70M
-General & Admin Expense – – – – $2.74B
Net Non-Operating Interest Income (Expense) – – – – -$114.60M
Non-Operating Interest Income – – – – $65.00M
Non-Operating Interest Expense – – – – $179.60M
Gain on Sale of Security – – – – $46.90M

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $142.28B $116.58B $112.48B $112.48B $114.94B
Total Current Assets $64.67B $54.84B $55.63B $55.63B $62.07B
Cash and Cash Equivalents & Short-Term Investments $8.95B $5.28B $7.27B $7.27B $9.91B
-Cash and Cash Equivalents $8.95B $5.28B $7.27B $7.27B $9.79B
Receivables $23.48B $21.18B $20.16B $20.16B $19.46B
-Accounts Receivable $20.08B $18.43B $17.76B $17.76B $16.11B
-Other Receivables $3.39B $2.75B $2.40B $2.40B $3.35B
Prepaid Assets $15.37B $13.63B $14.32B $14.32B $20.25B
Inventory $16.79B $14.53B $13.74B $13.74B $12.18B
Other Current Assets $86.00M $214.00M $147.00M $147.00M $271.50M
Total Non-Current Assets $77.61B $61.74B $56.85B $56.85B $52.86B
Net PPE $29.29B $26.54B $24.67B $24.67B $22.32B
-Gross PPE $42.39B – $37.23B $37.23B $34.73B
-Accumulated Depreciation -$13.10B – -$12.56B -$12.56B -$12.41B
Investments and Advances $3.86B $3.12B $2.80B $2.80B $2.81B
-Available for Sale Securities $1.25B $868.00M $668.00M $668.00M $644.90M
-Long Term Equity Investment $2.61B $2.25B $2.13B $2.13B $2.04B
Goodwill and Other Intangible Assets $26.96B $13.50B $12.42B $12.42B $12.34B
-Goodwill $8.85B $6.13B $5.90B $5.90B $5.90B
-Other Intangible Assets $18.11B $7.37B $6.52B $6.52B $6.45B
Non-Current Deferred Assets $10.03B $11.35B $9.96B $9.96B $8.96B
Other Non-Current Assets $7.48B $7.23B $6.99B $6.99B $6.43B
Total Liabilities $108.40B $85.38B $85.94B $85.94B $91.08B
Total Current Liabilities $47.74B $36.63B $35.23B $35.23B $40.14B
Payables $6.11B $5.03B $5.38B $5.38B $13.71B
-Accounts Payable $6.11B $5.03B $5.38B $5.38B $4.26B
Current Accrued Expenses $21.12B $17.55B $17.38B $17.38B $17.62B
Short-Term Debt and Capital Lease Obligation $7.05B $4.00B $1.64B $1.64B $1.63B
-Current Debt $7.05B $4.00B $1.64B $1.64B $1.63B
Other Current Liabilities $11.66B $8.70B $8.46B $8.46B $5.22B
Total Non-Current Liabilities $60.66B $48.74B $50.71B $50.71B $50.94B
Long Term Accounts Payable and Other Payables $5.46B $5.29B $5.88B $5.88B $6.29B
Long Term Debt and Capital Lease Obligation $47.86B $39.37B $40.87B $40.87B $40.87B
-Long Term Debt $47.86B $39.37B $40.87B $40.87B $40.87B
Other Non-Current Liabilities $7.34B $4.09B $3.97B $3.97B $3.78B
Total Equity $33.88B $31.20B $26.54B $26.54B $23.85B
Stockholders' Equity $33.88B $31.20B $26.54B $26.54B $23.79B
Capital Stock $588.00M $590.00M $590.00M $590.00M $591.40M
-Common Stock $588.00M $590.00M $590.00M $590.00M $591.40M
Additional Paid-In Capital $7.12B $6.92B $7.35B $7.35B $7.23B
Retained Earnings $31.89B $29.51B $24.47B $24.47B $22.25B
Gains/Losses Not Affecting Retained Earnings -$2.76B -$2.83B -$2.88B -$2.88B -$3.21B
Other Equity Interests -$2.96B -$2.99B -$2.99B -$2.99B -$3.01B
-Short Term Investments – – – – $121.60M
-Held to Maturity Securities – – – – $119.30M
-Total Tax Payable – – – – $9.44B
Less: Treasury Stock – – – – $62.50M
Minority Interests – – – – $57.50M

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $10.69B $5.33B $16.81B $3.22B $8.84B
Net cash flow from continuing operations $10.69B $5.33B $16.81B $3.22B $8.84B
Net Income from Continuing Operations $7.10B $7.40B $20.64B $6.64B $5.58B
Depreciation & Depletion & Amortization $534.00M $509.00M $2.00B $585.70M $470.30M
Deferred Tax $1.05B -$1.48B -$1.71B -$748.10M $501.10M
Other Non-Cash Items $2.49B $409.00M $3.53B $467.30M $922.70M
Change in Working Capital -$670.00M -$1.66B -$8.09B -$3.67B $1.21B
Net cash flow from investing -$15.40B -$3.92B -$10.97B -$2.80B -$2.98B
Net Cash Flow from Continuing Investing Activities -$15.40B -$3.92B -$10.97B -$2.80B -$2.98B
Net PPE Purchase and Sale -$2.93B -$2.33B -$7.84B -$2.55B -$2.09B
Net Intangibles Purchase and Sale -$3.28B -$204.00M -$2.79B -$205.70M -$720.30M
Net Business Purchase and Sale -$8.75B -$1.06B -$661.00M -$111.60M -$549.40M
Net Investment Purchase and Sale -$307.00M -$297.00M $319.00M $5.00M $682.00M
Net Other Investing Changes -$127.00M -$31.00M $1.00M $56.80M -$307.80M
Financing Cash Flow $8.43B -$3.47B -$2.21B -$2.88B $530.80M
Net Cash Flow from Continuing Financing Activities $8.43B -$3.47B -$2.21B -$2.88B $530.80M
Net Issuance Payments Of Debt $11.58B $1.03B $8.05B -$500,000.00 $2.61B
Net Common Stock Issuance -$1.60B -$2.36B -$4.11B -$1.51B -$708.30M
Cash Dividends Paid -$1.55B -$1.55B -$5.38B -$1.35B -$1.35B
Net Other Financing Charges -$4.00M -$591.00M -$772.00M -$25.10M -$29.90M
Ending Cash Balance $8.95B $5.28B $7.27B $7.27B $9.79B
Net Change in Cash $3.72B -$2.05B $3.63B -$2.46B $6.38B
Beginning Cash Balance $5.28B $7.27B $3.27B $9.79B $3.38B
Effect of Exchange Rate Changes -$52.00M $67.00M $372.00M -$67.10M $32.10M
Free Cash Flow $4.48B $2.80B $5.96B $254.20M $6.03B
Gain/Loss from Continuing Operations – – -$180.00M – –
-Change in Receivables – – -$7.00B – –
-Change in Inventory – – -$4.67B – –
-Change in Prepaid Assets – – -$6.61B – –
-Change in Payables and Accrued Expense – – $10.19B – –
Scroll to Top